Reviewed by The Peptide Dispatch Editorial Team · Last reviewed July 6, 2026
FGL (L) (FGL) is a cognitive peptide, at the preclinical stage in the published literature. Synthetic peptide mimetic of NCAM that promotes neuroplasticity and has shown cognitive enhancing effects in research.
Synthetic peptide mimetic of NCAM that promotes neuroplasticity and has shown cognitive enhancing effects in research.
| Research Status | Preclinical |
|---|---|
| Half-Life | Unknown |
| Administration | Subcutaneous injection |
| Doses Reported in Published Studies | 1-2 mg |
Mimics NCAM cell adhesion molecule effects, promoting synaptic plasticity and neuronal communication.
Synthetic peptide mimetic of NCAM that promotes neuroplasticity and has shown cognitive enhancing effects in research.
Mimics NCAM cell adhesion molecule effects, promoting synaptic plasticity and neuronal communication.
FGL (L) is at the following stage in the published literature: Preclinical. All information is for research and educational purposes only.
Reported half-life: Unknown.
Reported administration route in the literature: Subcutaneous injection. This is not a recommendation for human use.
Educational content, not medical advice. Effects described are drawn from cited research in study subjects.